G A Wells
About
In The Last Decade
G A Wells
9 papers receiving 463 citations
Peers
Comparison fields: 5 of 88
- Rheumatology 244
- Public Health, Environmental and Occupational Health 89
- Surgery 86
- Hematology 74
- Orthopedics and Sports Medicine 58
Countries citing papers authored by G A Wells
This map shows the geographic impact of G A Wells's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G A Wells with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G A Wells more than expected).
Fields of papers citing papers by G A Wells
This network shows the impact of papers produced by G A Wells. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G A Wells. The network helps show where G A Wells may publish in the future.
Co-authorship network of co-authors of G A Wells
This figure shows the co-authorship network connecting the top 25 collaborators of G A Wells. A scholar is included among the top collaborators of G A Wells based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G A Wells. G A Wells is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | The effect of low dose methotrexate on bone density. | 62 |
| 3 | Dictated versus database-generated discharge summaries: a randomized clinical trial. | 77 |
| 4 | Responsiveness of endpoints in osteoporosis clinical trials--an update. | 17 |
| 5 | The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials. | 134 |
| 6 | A cost effectiveness analysis of cyclosporine in rheumatoid arthritis. | 30 |
| 7 | Percentile curve reference charts of physical function: rheumatoid arthritis population. | 20 |
| 8 | Cyclosporin A in rheumatoid arthritis: overview of efficacy. | 24 |
| 9 | Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exercise. | 128 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.